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Abstract
Purpose Compare wide-field Optomap
imaging and optical coherence tomography
(OCT) with clinical examination in diabetic
retinopathy (DR).
Methods Patients referred from Diabetic Eye
Screening Programmes to three centres
underwent dilated ophthalmoscopy and were
assigned a DR grade. Wide-field colour
imaging and OCT were then examined by the
same clinician at that visit and a combined
grade was assigned. Independent graders
later reviewed the images and assigned an
imaging-only grade. These three grades
(clinical, combined, and imaging) were
compared. The method that detected the
highest grade of retinopathy, including
neovascularisation, was determined.
Results Two thousand and forty eyes of
1023 patients were assessed. Wide-field
imaging compared with clinical examination
had a sensitivity and specificity of 73% and
96%, respectively, for detecting proliferative
DR, 84% and 69% for sight-threatening DR,
and 64% and 90% for diabetic macular
oedema. Imaging alone found 35 more eyes
with new vessels (19% of eyes with new
vessels) and the combined grade found 14
more eyes than clinical examination alone.
Conclusions Assessment of wide-field
images and OCT alone detected more eyes
with higher grades of DR compared with
clinical examination alone or when combined
with imaging in a clinical setting. The
sensitivity was not higher as the techniques
were not the same, with imaging alone being
more sensitive. Wide-field imaging with OCT
could be used to assess referrals from DR
screening to determine management, to
enhance the quality of assessment in clinics,
and to follow-up patients whose DR is above
the screening referral threshold but does not
actually require treatment.
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Introduction
Photographic screening in patients with
diabetes has reduced the incidence of blindness
in England.1,2 The rising prevalence of diabetes
and increased options for the treatment of
diabetic retinopathy (DR) is causing significant
problems with providing capacity for managing
patients referred from diabetic eye screening.3,4
The quality of clinical assessment after entering
the hospital system may also be variable and is
difficult to audit. Screening for DR moved from
clinical assessment to photography, so could the
hospital service do the same?
The prevalence of referable grade DR in the
screened population is between 6 and 20%,5–7
although only about 10% of referred patients are
treated. Treatment options have changed to
include intravitreal injections, which require
more frequent visits and monitoring than that
required for laser. The total number of people
with diabetes globally is projected to rise from
171 million in 2000 to 366 million in 2030.8 In
2011–2012, 2.59 million people in England aged
12 years and over were identified with diabetes,
and 2.36 million were offered screening,
of whom 1.91 million received screening
(http://diabeticeye.screening.nhs.uk/statistics
(last accessed 30 May 2014)). This calls for
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efficient ways of managing diabetic eye clinics and
effectively triaging the referred patients into those who
actually need treatment, from those requiring closer
review. Clinicians currently decide the DR grade by slit
lamp examination and it is assumed that they are right.
One study found that there was only moderate
agreement between the retinal findings described by
clinicians using biomicroscopy and the results from
graders analysing screening photographs. Most of the
errors were found to be by the clinician when the DR
screening photographs were reanalysed.9
Seven-field colour stereo photography has been set as a
gold standard for the detection of DR but this is
technically difficult, time consuming, and taxing for both
patients and operators.10 In one study, which compares
two-field to seven-field images, 31.6% of the seven-field
stereo photosets were ungradeable by strict quality
criteria and 15.3% by less strict criteria.10 Slit lamp
biomicroscopy by an experienced ophthalmologist
compares favourably with seven-field
stereophotography. Two other imaging techniques may
allow an equivalent or improved assessment of the
retina: optical coherence tomography (OCT) and
wide-field colour imaging. The Optos (Optos PLC,
Dunfermline, Scotland, UK) system uses an ellipsoid
mirror to produce images (called Optomap) with B200
internal degrees of view, providing an image of over 80%
of the retina in a single image. OCT allows objective
evaluation of diabetic maculopathy. OCT performs well
compared with fundus stereo photography and
outperforms biomicroscopy.11 It is now being used
in conjunction with some screening programmes
to improve diabetic maculopathy assessment and
follow-up.12
We therefore decided to determine the method of
assessment of DR that detects the maximum amount of
diabetic pathology and to compare agreement between
different methods of assessing DR grades using clinical
examination, clinical examination with additional access
to Optomap wide-field images and OCT, or assessment
of the retinal images alone.
Methods
This was a multisite, prospective, clinic-based study
conducted to evaluate the agreement in assessing
severity of DR at the grade level between clinical retinal
examination through dilated pupils, the 200-degree
Optomap wide-field images with OCT scans, and a
combination of clinical examination and imaging. Ethical
approval was obtained from the Northern Regional
Ethics Committee and the NHS Trust Research
departments at three sites: Royal Victoria Infirmary,
Newcastle upon Tyne, Sunderland Eye Infirmary, and
Frimley Park Hospital. The patients were recruited from
those referred by the DR Screening Service.
After informed consent, visual acuity recording and
mydriasis, OCT scans and wide-field Optomap images were
taken and an ophthalmologist performed a clinical
examination at the slit lamp using 90 and 60 D lenses.
Individual retinal lesions were recorded on a proforma
leading to a retinopathy grade, which was then filed away
by the research nurse. The same ophthalmologist then
viewed the imaging in the clinic, filled another copy of the
proforma, and gave a grade, combining imaging with
clinical findings. The examinations were performed by 10
trained ophthalmologists employed in the diabetic eye
clinics in three hospitals at Senior Registrar, Fellow and
Consultant level, and so should reflect clinical practice
rather than the expertise of an individual. The images were
independently graded at a reading centre whose quality
assurance processes would ensure good reliability. Special
attention was given to confirm definite appearance of new
vessels rather than haemorrhage or intraretinal
microvascular abnormalities. In all the cases where there
was a disagreement between the reading centre findings
and the clinician findings, we looked at the images to double
check whether we could see new vessels or not (SJT, VM). In
doubtful cases, the lesion was not classified as new vessels.
Imaging was performed by certified medical
photographers using:
(1) Optomap P2000: Scanning laser ophthalmoscope, with
field up to 2001. Eye steering was used to obtain three
images of each eye: centre, looking up, and looking
down. Images were reviewed using proprietary
image review software (Optos V2 Vantage Dx Review
version 2.5.0.135; Optos PLC). Grading for each wide-
field image involved viewing the colour composite,
green-wavelength, and red-wavelength images using
all the available adjustments.
(2) OCT: Spectral domain OCT was carried out. In this
study, macular oedema was defined as OCT retinal
thickness of 300mm or greater, with associated focal
changes such as cysts, within one disc diameter of the
centre of the fovea (ie in any of the five central ETDRS
map regions). The 3D acquisition mode was used
with the camera centred on the macular fixation
point. A 6 6 cm2 scan area with 128 lines of 512
A-scans per line was acquired.
Statistical analysis
The clinical NSC (National Screening Committee) levels
of DR severity were compared, the agreement between
clinical grading of DR severity and wide-field images
and the combined grade were cross-tabulated, and
k-values were calculated. Eyes classified as ungradable
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were excluded from the analysis. Guidelines for
interpretation were based on Landis and Koch (ETDRS
report 10: 0.0–0.2¼ slight agreement; 0.21–0.40¼ fair
agreement; 0.41–0.60¼moderate agreement; 0.61–0.80¼
substantial agreement; and 0.81–1.00¼ almost perfect
agreement). Additional sensitivity, specificity, positive,
and negative likelihood ratios were calculated after
treating DR severity level as a binary variable with
clinically important thresholds:
(1) R1 vs R2þR3, that is, ‘dischargeable’ patients vs
those with sight-threatening DR.
(2) R1þR2 vs R3, that is, non-proliferative vs prolifera-
tive DR.
(3) Clinically significant macular oedema (CSMO) vs no
diabetic maculopathyþnon-CSMO maculopathy.
(4) No diabetic maculopathy vs any maculopathy.
R1 indicates the background DR; R2 the preproliferative
DR; and R3 the proliferative retinopathy.
Such comparisons are useful if one technique is similar
to another; however, if not, the issue is to determine the
more sensitive technique. Therefore, we measured which
technique detected the maximum number of eyes with
proliferative DR (R3) and clinically significant macular
oedema (CSMO). We also assessed the frequency with
which the clinician changed their grade when they
examined the images. Analyses were performed using
SPSS version 19 (SPSS, Chicago, IL, USA). All analyses
were carried out per eye and not per patient.
Results
Overall data
One thousand and twenty-three consecutive patients
were recruited from three centres (2046 eyes). Of these,
910 patients (1820 eyes) were referrals from screening
and 113 eyes were from follow-up clinics. Previous laser
treatment (18 PRP, 67 macular) was present in 85 eyes.
The screening grade was available for 1580 eyes. There
was technical failure in obtaining wide-field images in
three patients. Wherever data was missing, these eyes
were removed from that particular comparison. The
images were deemed ungradable either due to
inadequate quality or media opacity in 23 eyes.
The distribution of retinopathy severity is shown in
Table 1a. All patients had DR in at least one eye requiring
referral, and hence there are some eyes with no DR in the
cohort.
Table 1b shows the cross-tabulation of screening to the
clinical, combined, and imaging grades. k-Statistic for
agreement did not include ungradable eyes or missing
data.
Clinician vs imaging-only comparisons
Comparison between clinical examination and imaging
(Table 2a) shows exact agreement of levels in 59.4% of
eyes. The clinical examination was taken as the reference
standard. There was fair agreement (k¼ 0.386) across all
four levels of DR. Imaging alone detected 73 more eyes
with new vessels not seen by the clinician (3þ 22þ 48),
and the clinician alone detected new vessels in 39 eyes
not detected on imaging (2þ 8þ 29). Overall imaging
diagnosed more PDR and severe NPDR than did clinical
examination. There were two eyes given a clinical grade
as proliferative DR, but an imaging grade of no
retinopathy. These were rechecked and found to have
collateral vessels. Therefore, 20 eyes were said to have
new vessels on clinical examination, which were not seen
on imaging. This either means that imaging missed it or
demonstrates that clinical decisions can be difficult when
deciding between intraretinal microvascular abnormalities
(IRMA), haemorrhage, and new vessels, as suggested by
Table 1b Cross-tabulation of grades between screening, clinical
examination, and imaging (1580 eyes)
Screening Clinical Combined grade Imaging alone
R0 R1 R2 R3 R0 R1 R2 R3 R0 R1 R2 R3
R0 50 18 3 0 42 22 4 0 47 20 2 2
R1 137 732 118 5 86 675 214 9 122 540 319 17
R2 19 109 210 15 10 82 253 10 9 90 235 24
R3 6 25 39 71 4 15 44 76 7 23 43 72
Total 210 884 370 91 142 794 515 95 185 673 599 115
k¼ 0.446 k¼ 0.314 k¼ 0.449
Abbreviations: R0, no DR; R1, mild NPDR; R2, moderate–severe DR; R3,
proliferative DR.
Table 1a Frequency of DR grades (eyes)
Clinical Combined Imaging Screening
Valid data
No DR 274 198 229 71
Mild NPDR 1074 966 818 1004
Moderate–severe NPDR 504 664 791 358
Proliferative DR 147 152 179 147
Total 1999 1980 2017 1580
Missing
Technical 41 58 6 465
Ungradable 6 8 23 1
Total 47 66 29 466
Total 2046 2046 2046 2046
Abbreviations: screening, grade from National Screening Programme;
clinical¼ slit lamp biomicroscopy; imaging, independent wide-field
OptomapþOCT; combined, combination of slit lamp with OptomapþOCT;
DR, diabetic retinopathy; NPDR, non-proliferative diabetic retinopathy.
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the 17 cases in which the clinician changed their mind on
reviewing the images. Also, on two-dimensional images,
small flat new vessels can be difficult to distinguish from
IRMA and the graders could have therefore undergraded
these images.
The DR severity was changed to a binary variable to
compare treatable (ie proliferative) vs that not needing
treatment. The grades were also transformed to
differentiate eyes with sight-threatening DR (STDR)
from those with non-STDR that could be discharged
to annual screening. Table 2b shows the sensitivity,
specificity, agreement, and likelihood ratios
comparing clinical examination to wide-field
imaging at these cutoff levels. Wide-field imaging
had a sensitivity of 73% and specificity of 96% for
detecting proliferative DR. The sensitivity was 84%
and specificity was 69% in differentiating STDR from
non-STDR.
For maculopathy, the comparisons were performed at
two cutoff levels, that is, the presence or absence of any
maculopathy separate from CSMO (the ETDRS
definitions were used).
The clinical grading was taken as standard, although
we found that including OCT makes imaging sensitive to
the presence of macular oedema. The overall agreement
over the three different grades of maculopathy (ie absent,
exudates only, and CSMO) was 0.380, but imaging was
64% sensitive and 90% specific in detecting CSMO
(Table 2b).
Clinical vs combined grade comparisons
The clinical examination was compared with the
combined grade assigned by the clinician in conjunction
with imaging (Table 3a). Exact agreement was seen in
80.7%. There was substantial agreement (k¼ 0.695) across
all four levels of retinopathy. The combination grade
detected 22 more eyes with new vessels. Interestingly, the
clinician seemed to have altered the grade in 17 eyes,
which they initially graded as R3, after viewing the wide-
field images. The variation of clinical judgment is also
highlighted where 29 mild non-proliferative cases was
changed to no retinopathy after including imaging.
When the combined grade was taken as the reference
standard (Table 3b), we found the clinical examination to
be 85% sensitive and 99% specific for proliferative
retinopathy. Clinical examination was 75% sensitive and
97% specific for deciding on STDR vs patients with non-
sight-threatening retinopathy that could be discharged to
screening.
Table 3b give the comparisons between clinical
examination alone and combined grades. Adding OCT to
the assessment of maculopathy improves the sensitivity
and specificity of detecting CSMO as well as any
maculopathy (ie exudates only)
Combination vs imaging-alone grade comparisons
When compared with the combination grade, imaging
showed exact agreement in 64.6% of eyes (Table 4a).
There was moderate overall agreement on the four
different levels of retinopathy (k¼ 0.459). The imaging
grade picked up 60 more eyes with new vessels. This
could be because of the difficulty in deciding between
treated (and fibrosed) new vessels and active vessels.
Eighteen patients had previously had PRP laser, and after
removing these from analysis, there were 35 more eyes
found to have new vessels with imaging only and 14
more with the combined compared with clinical
examination alone.
The combined grade was used as the reference standard
to compare with imaging only in Table 4b. Imaging was
79% sensitive and 97% specific in detecting proliferative
DR. The decision on STDR vs non-sight-threatening DR
Table 2a Clinician grade imaging-only grade cross-tabula-
tion (k¼ 0.386)
Imaging only grade Total
No
DR
Mild
NPDR
Mod–
severe
NPDR
Prolif
DR
Clinician grade
No DR 120 135 31 3 289
Mild NPDR 79 591 352 22 1044
Moderate–severe NPDR 5 87 360 48 500
Proliferative DR 2 8 29 103 142
Total 206 821 772 176 1975
Table 2b Comparison at different thresholds between clinical and imaging grades
Cutoff k Sensitivity CI Specificity CI LRþ CI LR CI
Proliferative vs non-proliferative 0.617 0.73 0.65–0.79 0.96 0.95–0.97 18.21 14.23–23.30 0.29 0.22–0.37
Non-STDR vs sight threatening DR 0.476 0.84 0.81–0.87 0.69 0.67–0.72 2.75 2.52–2.99 0.23 0.19–0.28
CSMO vs no CSMO 0.440 0.64 0.57–0.71 0.90 0.89–0.92 6.89 5.78–8.22 0.39 0.33–0.48
Any maculopathy vs no maculopathy 0.440 0.72 0.68–0.76 0.78 0.76–0.80 3.24 2.91–3.60 0.36 0.32–0.42
Abbreviations: CI, confidence interval; LRþ and LR , positive and negative likelihood ratios.
N¼ 1975 for retinopathy; N¼ 2110 for maculopathy.
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was 81% sensitive and 75% specific. The specificity
remains very high with imaging-alone grades regardless
of whether clinical examination is included in the
assessment.
A comparison between screening and imaging was not
carried out for maculopathy as the screening grades do
not use OCT for referral. From Tables 2b, 3b, and 4b we
see that imaging-alone detects the maximum numbers of
eyes with CSMO and the likelihood ratios are most
favourable with a combination of wide-field imaging
with OCT.
Discussion
The success of retinal photography in screening for
treatable DR1,2,5 led to the establishment of a UK
National Screening Programme. Subsequently, a decrease
in the rate of blindness due to diabetes in the working
age population has been demonstrated.2,13 However, the
workload generated for Ophthalmology departments has
been considerable and this continues to increase in step
with the increasing prevalence of diabetes. A more
efficient means of triaging those requiring active
treatment is required.
This study was designed to evaluate whether wide-
field imaging and OCT could be used to improve the
management of patients in diabetic eye clinics in the
Hospital Eye Service (HES). The study population
therefore comprised patients who were already known to
have some form of retinopathy and had been referred as
such. Previously wide-field imaging has been studied as
a screening modality with a sensitivity of 94% and a
specificity of 100% for detection of retinopathy.14 That
study was performed in a setting similar to ours, that is,
in diabetic eye clinics where higher levels of DR were
expected. In another study, the patient population was a
mixture from the general population in a screening
service as well as from DR clinics. They reported a
sensitivity of 83% and specificity of 89% for detecting
referable DR.15 Our study had a sensitivity of 84% and a
specificity of 69% for STDR, with the clinical findings as
the reference standard. For detecting proliferative DR,
the sensitivity was 73% and specificity rose to 96%. Our
study has a negative bias as the study population are
patients known to have DR and already within the HES.
Previous studies have shown that Optos colour
imaging compares well with clinical examination and
ETDRS colours.15,16 However, these may have involved
especially expert examiners and the number of patients
involved was relatively small so the number of patients
with new vessels was small. Our study was powered
with enough patients to show a difference in the ability
of the techniques at detecting pathology. By having 10
different ophthalmologists from three centres, this was
less likely to bias the study than only having one or two
who were either unusually good or unusually bad.
We standardised the examinations in that the examiners
had a specific proforma to record the findings with the
different ETDRS findings and associated grades
specified. The patients were also seen in research
clinics so the examiners had longer time to examine
the patient than may be possible in standard clinical
practice.
The ophthalmologists involved were not trained as
graders but were used to looking at Optomap images in
their clinical practice. Compared with the
ophthalmologists involved in the study, more pathology
was found by a reading centre examining the images
than by the ophthalmologists. This suggests that imaging
alone could be used as a way of assessing patients with
DR and could be used to quality control examinations
being performed. Maybe better training of the
ophthalmologists involved in examining the patients and
Table 3a Clinician grade combined grade cross-tabulation
(k¼ 0.695)
Combined grade Total
No
DR
Mild
NPDR
Mod–severe
NPDR
Prolif
DR
Clinician grade
No DR 167 88 11 2 268
Mild NPDR 29 837 183 3 1052
Mod–severe NPDR 0 30 451 17 498
Prolif DR 1 4 12 129 146
Total 197 959 657 151 1964
Table 3b Comparison at different thresholds between clinical and combined grades
Cutoff k Sensitivity CI Specificity CI LRþ CI LR CI
Proliferative vs nonprolif 0.858 0.85 0.79–0.90 0.99 0.99–0.99 91.11 56.51–146.90 0.15 0.1–0.22
Non-STDR vs sight-threatening DR 0.746 0.75 0.72–0.78 0.97 0.96–0.98 24.89 17.92–34.58 0.25 0.23–0.29
CSMO vs no CSMO 0.623 0.78 0.72–0.83 0.94 0.93–0.95 13.30 10.95–16.15 0.23 0.18–0.30
Any maculopathy vs no maculopathy 0.679 0.88 0.85–0.91 0.86 0.85–0.88 6.45 5.67–7.33 0.14 0.11–0.17
Abbreviations: CI, confidence interval; LRþ and LR , positive and negative likelihood ratios.
N¼ 1964 for retinopathy; N¼ 2110 for maculopathy.
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examining the images in this study would have meant
less pathology was missed.
The British Association of Retinal Screeners
recommends a sensitivity of 80% and specificity of at
least 95% for referable retinopathy.7 In our study, the
cutoff points used were the presence of treatable
retinopathy and the ability to distinguish between those
who need some follow-up (ie sight-threatening) and
those who could be discharged from the HES. More
severe retinopathy, proliferative retinopathy, and
macular oedema were found with imaging alone.
The English National Screening Committee
recommends that any camera should have about 20
pixels degree in both axes.17 A division of the Optomap
sensors’ megapixels by the external angles achieves a
resolution of about 14 pixels/degree in the horizontal
axis and 20 pixel/degree in the vertical axis. However,
this does not consider the differential distribution of
pixels, which are densest in the centre for the Optomap.
In this study, we used mydriasis and steering up and
down, thus three pictures per eye, to increase the
resolution and enable better grading.
With regards to diabetic maculopathy and clinically
significant macular oedema, OCT is in routine use in
several centres. However, the decision to treat with laser
continues to be based on the ETDRS criteria.18
The ETDRS used contact lens biomicroscopy and this
was deemed to agree very closely with stereoscopic
photography.19 Currently, most units use non-contact
biomicroscopy to evaluate macular oedema in the clinic,
but OCT allows both objective and quantitative
assessment. Subclinical foveal oedema is being
recognised as an entity, especially if a lower threshold of
retinal thickness is used. This study used the central
thickness of 300 mm as the threshold. This number gave
the highest specificity in previous studies but varies with
different OCT machines.20 There were eyes with cysts
and thickening on OCT, albeit the thickness remained
below 300 mm. These were graded as CSMO for imaging
only, but additional visual acuity data was used to guide
grading and treatment decisions in the clinical grades.
A review of the use of OCT in diabetic macular oedema
reported sensitivities ranging from 0.67 to 1.00 and
specificities from 0.77 to 0.96.11 The higher values were
from studies using healthy controls,21 which would
always increase performance indices for a diagnostic test.
Our study gave a sensitivity of 64% and specificity of
90%, which increased to 94% when the combination of
examination and imaging was used. The pooled
likelihood ratios were 6.5 (positive) and 0.24 (negative) in
the meta-analysis by Virgili et al.11
For CSMO, our study showed a positive likelihood
ratio of 6.5 (positive) and 0.39 (negative) for imaging
only. A likelihood ration of 45 (positive) and o0.2
(negative) is believed to be convincing evidence.11
For any maculopathy, the grades were less convincing
(Tables 2b, 3b, and 4b). This is because there was a
reliance on the presence of exudates, haemorrhages, and
visual acuity, all of which made the grades very variable.
The sensitivities and specificities were around 80%,
which serves to underline the utility of the two imaging
modalities.
In the paper by Sallam et al,9 agreement between
screening grades and clinical assessment gave a k-value
of 0.4, with most of the disagreement being due to the
clinician failing to detect small amounts of exudates,
which was apparent on the images. However, small
amounts of exudate may not relate to thickening, which
is objectively measured on OCT. There was also a
tendency for screening to overgrade and doctors to
undergrade. It is also possible that in our study there was
overcall by image grading particularly for R2. The
differentiation of small IRMA from haemorrhage and
from small NVE can be difficult with both images and on
Table 4b Comparison at different thresholds between imaging and combined grades
Cutoff k Sensitivity CI Specificity CI LRþ CI LR CI
Proliferative vs non-proliferative 0.697 0.79 0.72–0.85 0.97 0.96–0.97 23.94 18.42–31.12 0.22 0.16–0.29
Non-STDR vs sight-threatening DR 0.540 0.81 0.78–0.83 0.75 0.72–0.77 3.17 2.86–3.52 0.26 0.22–0.30
CSMO vs no CSMO 0.624 0.72 0.67–0.77 0.94 0.93–0.95 11.95 9.83–14.54 0.29 0.24–0.36
Any maculopathy vs no maculopathy 0.512 0.70 66–0.73 0.82 0.80–0.84 3.95 3.49–4.47 0.37 0.33–0.41
Abbreviations: CI, confidence interval; LRþ and LR , positive and negative likelihood ratios.
N¼ 1963 for retinopathy; N¼ 2110 for maculopathy with 27 missing data.
Table 4a Imaging-only grade combined grade cross-tabula-
tion (k¼ 0.459, fair agreement)
Combined grade Total
No
DR
Mild
NPDR
Mod–severe
NPDR
Prolif
DR
Imaging-only grade
No DR 111 105 6 1 223
Mild NPDR 69 575 144 4 792
Mod–severe NPDR 15 264 465 26 770
Prolif DR 1 14 45 118 178
Total 196 958 660 149 1963
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clinical examination. To further enhance diabetic retinal
assessment, fundus fluorescein angiography may be
required. Compared with many previous papers, our
study was large enough to assess the detection of new
vessels, Sallam et al9 reported only nine cases.
In summary, more sight threatening DR was found on
assessing images alone compared with clinical examination,
or by combining clinical examination with assessing images
in the clinical setting. As with clinical assessments,
appropriate training and quality control is required to
ensure standards of assessment. We believe that assessing
wide-field imaging along with OCT is the best way to
diagnose treatable DR. It could be used to assess referrals
from DR screening to determine further management, to
enhance the quality of assessment of DR in clinics when
used in combination with examination, to audit the quality
of clinical assessments being made in a clinic and to follow-
up patients who have too much retinopathy to return to
screening but do not actually need treatment.
Summary
What was known before
K Digital photography has been considered the most
reliable and useful method of screening for DR.
K Ultra-wide-field Optomap imaging allows a larger area of
the fundus to be assessed. OCT is reliable and
reproducible in assessing macular oedema.
K Slit lamp biomicroscopy of the fundus by an
ophthalmologist is the standard clinical method for
diagnosis of DR in the Hospital Eye Service.
What this study adds
K Ultra-wide-field Optomap imaging enabled earlier
diagnosis of higher grades of DR in a larger number of
patients than the clinicians in this study.
K Ultra-wide-field imaging along with OCT is useful in
diagnosing and grading sight-threatening DR and this
could be used in ’virtual diabetic eye clinics’.
K This combination could be used to quality control
examinations or as an alternative method of assessment.
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